Logo image of CKX

CKX LANDS INC (CKX) Stock Fundamental Analysis

NYSEARCA:CKX - NYSE Arca - US12562N1046 - Common Stock - Currency: USD

10.9  -0.05 (-0.49%)

Fundamental Rating

5

CKX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Real Estate Management & Development industry. CKX has an excellent financial health rating, but there are some minor concerns on its profitability. CKX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CKX had positive earnings in the past year.
In the past year CKX had a positive cash flow from operations.
Of the past 5 years CKX 4 years were profitable.
Of the past 5 years CKX 4 years had a positive operating cash flow.
CKX Yearly Net Income VS EBIT VS OCF VS FCFCKX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

CKX has a Return On Assets of 1.33%. This is in the better half of the industry: CKX outperforms 72.31% of its industry peers.
CKX has a better Return On Equity (1.35%) than 67.69% of its industry peers.
CKX has a Return On Invested Capital (0.11%) which is in line with its industry peers.
Industry RankSector Rank
ROA 1.33%
ROE 1.35%
ROIC 0.11%
ROA(3y)-1.79%
ROA(5y)0.3%
ROE(3y)-1.81%
ROE(5y)0.33%
ROIC(3y)N/A
ROIC(5y)N/A
CKX Yearly ROA, ROE, ROICCKX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

With an excellent Profit Margin value of 16.45%, CKX belongs to the best of the industry, outperforming 89.23% of the companies in the same industry.
CKX's Profit Margin has declined in the last couple of years.
CKX has a Operating Margin of 2.06%. This is in the better half of the industry: CKX outperforms 61.54% of its industry peers.
In the last couple of years the Operating Margin of CKX has declined.
With an excellent Gross Margin value of 95.70%, CKX belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
In the last couple of years the Gross Margin of CKX has remained more or less at the same level.
Industry RankSector Rank
OM 2.06%
PM (TTM) 16.45%
GM 95.7%
OM growth 3Y-25.78%
OM growth 5Y-31.46%
PM growth 3Y-46.93%
PM growth 5Y-11.79%
GM growth 3Y1.02%
GM growth 5Y1.2%
CKX Yearly Profit, Operating, Gross MarginsCKX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CKX is destroying value.
The number of shares outstanding for CKX has been increased compared to 1 year ago.
Compared to 5 years ago, CKX has more shares outstanding
CKX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CKX Yearly Shares OutstandingCKX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
CKX Yearly Total Debt VS Total AssetsCKX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

CKX has an Altman-Z score of 52.59. This indicates that CKX is financially healthy and has little risk of bankruptcy at the moment.
CKX has a Altman-Z score of 52.59. This is amongst the best in the industry. CKX outperforms 100.00% of its industry peers.
There is no outstanding debt for CKX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 52.59
ROIC/WACC0.01
WACC9.11%
CKX Yearly LT Debt VS Equity VS FCFCKX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 36.26 indicates that CKX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 36.26, CKX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CKX has a Quick Ratio of 36.26. This indicates that CKX is financially healthy and has no problem in meeting its short term obligations.
CKX has a Quick ratio of 36.26. This is amongst the best in the industry. CKX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 36.26
Quick Ratio 36.26
CKX Yearly Current Assets VS Current LiabilitesCKX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 110.50% over the past year.
CKX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.10% yearly.
CKX shows a small growth in Revenue. In the last year, the Revenue has grown by 2.40%.
CKX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.40% yearly.
EPS 1Y (TTM)110.5%
EPS 3Y-33.9%
EPS 5Y-1.1%
EPS Q2Q%-86.3%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y26.89%
Revenue growth 5Y13.4%
Sales Q2Q%-73.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CKX Yearly Revenue VS EstimatesCKX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 99.09, which means the current valuation is very expensive for CKX.
Based on the Price/Earnings ratio, CKX is valued a bit cheaper than 61.54% of the companies in the same industry.
When comparing the Price/Earnings ratio of CKX to the average of the S&P500 Index (26.19), we can say CKX is valued expensively.
Industry RankSector Rank
PE 99.09
Fwd PE N/A
CKX Price Earnings VS Forward Price EarningsCKX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CKX's Enterprise Value to EBITDA ratio is in line with the industry average.
CKX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 109.11
EV/EBITDA 199.06
CKX Per share dataCKX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CKX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CKX LANDS INC

NYSEARCA:CKX (5/29/2025, 8:04:02 PM)

10.9

-0.05 (-0.49%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-12 2025-05-12
Earnings (Next)08-11 2025-08-11
Inst Owners9.02%
Inst Owner Change-12.04%
Ins Owners4.52%
Ins Owner Change0%
Market Cap22.34M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 99.09
Fwd PE N/A
P/S 14.69
P/FCF 109.11
P/OCF 109.11
P/B 1.2
P/tB 1.2
EV/EBITDA 199.06
EPS(TTM)0.11
EY1.01%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY0.92%
OCF(TTM)0.1
OCFY0.92%
SpS0.74
BVpS9.06
TBVpS9.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.33%
ROE 1.35%
ROCE 0.17%
ROIC 0.11%
ROICexc 0.21%
ROICexgc 0.21%
OM 2.06%
PM (TTM) 16.45%
GM 95.7%
FCFM 13.46%
ROA(3y)-1.79%
ROA(5y)0.3%
ROE(3y)-1.81%
ROE(5y)0.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-7.11%
ROICexcg growth 5Y-22.44%
ROICexc growth 3Y-7.11%
ROICexc growth 5Y-22.44%
OM growth 3Y-25.78%
OM growth 5Y-31.46%
PM growth 3Y-46.93%
PM growth 5Y-11.79%
GM growth 3Y1.02%
GM growth 5Y1.2%
F-Score7
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 250
Cash Conversion 573.67%
Profit Quality 81.82%
Current Ratio 36.26
Quick Ratio 36.26
Altman-Z 52.59
F-Score7
WACC9.11%
ROIC/WACC0.01
Cap/Depr(3y)303.54%
Cap/Depr(5y)413.1%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.5%
EPS 3Y-33.9%
EPS 5Y-1.1%
EPS Q2Q%-86.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.4%
Revenue growth 3Y26.89%
Revenue growth 5Y13.4%
Sales Q2Q%-73.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y210.99%
EBIT growth 3Y-5.83%
EBIT growth 5Y-22.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-76.08%
FCF growth 3YN/A
FCF growth 5Y4.05%
OCF growth 1Y-76.65%
OCF growth 3YN/A
OCF growth 5Y1.02%